Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (14)

2024

  1. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world

    Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937

2022

  1. Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study

    Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1856-1864

  2. Dietary Exposure to Polychlorinated Biphenyls and Dioxins and Its Relationship to Telomere Length in Subjects Older Than 55 Years from the SUN Project

    Nutrients, Vol. 14, Núm. 2

  3. Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events

    Journal of Clinical Medicine, Vol. 11, Núm. 17

  4. Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry

    Frontiers in Medicine, Vol. 9

  5. Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study

    Nefrologia, Vol. 42, Núm. 5, pp. 594-606

  6. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

    Viruses, Vol. 14, Núm. 2

2018

  1. MPGES-1 (Microsomal prostaglandin E synthase-1) mediates vascular dysfunction in hypertension through oxidative stress

    Hypertension, Vol. 72, Núm. 2, pp. 492-502

2015

  1. TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages

    Cardiovascular Research, Vol. 108, Núm. 1, pp. 139-147

2014

  1. Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis

    Journal of the American Heart Association, Vol. 3, Núm. 4

2012

  1. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress

    Journal of Hypertension, Vol. 30, Núm. 2, pp. 315-326

2009

  1. Increased CD74 expression in human atherosclerotic plaques: Contribution to inflammatory responses in vascular cells

    Cardiovascular Research, Vol. 83, Núm. 3, pp. 586-594

  2. The CD163-expressing macrophages recognize and internalize TWEAK. Potential consequences in atherosclerosis

    Atherosclerosis, Vol. 207, Núm. 1, pp. 103-110

2007

  1. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 4, pp. 916-922